Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 201 - 210 of 1441 shown below

  • García-Muñiz, J L

    F J Vizoso, L O González, M D Corte, J C Rodríguez, J Vázquez, M L Lamelas, S Junquera, A M Merino and J L García-Muñiz

    Study of matrix metalloproteinases and their inhibitors in breast cancer

    advance online publication, 2007-03-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603666

    Abstract | Full article | PDF

  • L O González, I Pidal, S Junquera, M D Corte, J Vázquez, J C Rodríguez, M L Lamelas, A M Merino, J L García-Muñiz and F J Vizoso

    Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

    advance online publication, 2007-09-11 00:00:00.000;

    doi:10.1038/sj.bjc.6603963

    Abstract | Full article | PDF

  • García-Navarrete, R

    O Arrieta, P Guevara, E Escobar, R García-Navarrete, B Pineda and J Sotelo

    Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma

    advance online publication, 2005-03-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602483

    Abstract | Full article | PDF

  • García-Suárez, O

    C G Viloria, J R Peinado, A Astudillo, O García-Suárez, M V González, C Suárez and S Cal

    Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin

    advance online publication, 2007-06-19 00:00:00.000;

    doi:10.1038/sj.bjc.6603856

    Abstract | Full article | PDF

  • Garcea, G

    G Garcea, D J L Jones, R Singh, A R Dennison, P B Farmer, R A Sharma, W P Steward, A J Gescher and D P Berry

    Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

    doi:10.1038/sj.bjc.6601623

    Abstract | Full article | PDF

  • Garcia, J F

    Al Sáez, E Sánchez, M Sánchez-Beato, M A Cruz, I Chacón, E Muñoz, F I Camacho, J C Martínez-Montero, M Mollejo, J F Garcia and M A Piris

    p27KIP1 is abnormally expressed in Diffuse Large B-Cell Lymphomas and is associated with an adverse clinical outcome

    doi:10.1038/sj.bjc.6690539

    Abstract | Full article | PDF

  • Garcia, J M

    J M Silva, G Dominguez, M J Villanueva, R Gonzalez, J M Garcia, C Corbacho, M Provencio, P España and F Bonilla

    Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients

    doi:10.1038/sj.bjc.6690495

    Abstract | Full article | PDF

  • R Gonzalez, J M Silva, G Dominguez, J M Garcia, G Martinez, J Vargas, M Provencio, P España and F Bonilla

    Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations

    doi:10.1038/sj.bjc.6690722

    Abstract | Full article | PDF

  • J M Garcia, R Gonzalez, J M Silva, G Dominguez, I S Vegazo, C Gamallo, M Provencio, P España and F Bonilla

    Mutational status of K- ras and TP53 genes in primary sarcomas of the heart

    doi:10.1054/bjoc.1999.1060

    Abstract | Full article | PDF

  • Garcia, M J

    R Fernández-Ramires, X Solé, L De Cecco, G Llort, A Cazorla, N Bonifaci, M J Garcia, T Caldés, I Blanco, M Gariboldi, M A Pierotti, M A Pujana, J Benítez and A Osorio

    Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis

    doi:10.1038/sj.bjc.6605275

    Abstract | Full article | PDF

  • Garcia, S

    S Garcia, J-P Dalès, J Jacquemier, E Charafe-Jauffret, D Birnbaum, L Andrac-Meyer, M-N Lavaut, C Allasia, S Carpentier-Meunier, P Bonnier and C Charpin-Taranger

    c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

    doi:10.1038/sj.bjc.6603569

    Abstract | Full article | PDF

  • C Charpin, S Giusiano, S Charfi, V Secq, S Carpentier, L Andrac, M-N Lavaut, C Allasia, P Bonnier and S Garcia

    Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome

    advance online publication, 2009-06-09 00:00:00.000;

    doi:10.1038/sj.bjc.6605113

    Abstract | Full article | PDF

  • Garcia-Alfonso, P

    P Garcia-Alfonso, A Muñoz-Martin, M Mendez-Ureña, R Quiben-Pereira, E Gonzalez-Flores and G Perez-Manga

    Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group

    advance online publication, 2009-09-08 00:00:00.000;

    doi:10.1038/sj.bjc.6605261

    Abstract | Full article | PDF

  • Garcia-Caballero, T

    M Raccurt, S P Tam, P Lau, H C Mertani, A Lambert, T Garcia-Caballero, H Li, R J Brown, M A McGuckin, G Morel and M J Waters

    Suppressor of cytokine signalling gene expression is elevated in breast carcinoma

    doi:10.1038/sj.bjc.6601115

    Abstract | Full article | PDF